Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.

Gynecologic oncology - 1 Nov 2008

Martinho Olga, Gonçalves Alberto, Moreira Marise A R, Ribeiro Luiz F J, Queiroz Geraldo S, Schmitt Fernando C, Reis Rui M, Longatto-Filho Adhemar

Abstract excerpt

OBJECTIVES: Uterine adenosquamous carcinoma (ASC) is an uncommon, yet, one of the most aggressive cervical cancer subtype. The successful treatment of some tumors, such as gastrointestinal stromal tumors (GISTs), by anti-KIT inhibitors fosters the study of this receptor tyrosine kinase in other malignancies. In the present study, we intended to molecularly characterize KIT in ASC. METHODS: In a series of 30...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Adenosquamous
Share to Enzyme Activation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Amplification

Share to Phosphorylation

Share to Polymorphism, Single-Stranded Conformational

Share to Proto-Oncogene Proteins c-kit

Share to Stem Cell Factor

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 18708242
DOI: 10.1016/j.ygyno.2008.07.011

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.PMID 18708242Read ↗

Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.Semantic proximity Read ↗

Targeting c-Kit mutations: basic science to novel therapies.Semantic proximity Read ↗

KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors.Semantic proximity Read ↗

Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.Semantic proximity Read ↗

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies.Semantic proximity Read ↗

The SCF/c-KIT system in the male: Survival strategies in fertility and cancerSemantic proximity Read ↗

Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer.Semantic proximity Read ↗

KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.Semantic proximity Read ↗

Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.Semantic proximity Read ↗

Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis.Semantic proximity Read ↗

C-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model.Semantic proximity Read ↗

Immunohistochemical evaluation of KIT expression in sarcomas of the gynecologic region.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.